Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if ODTX is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
20 top institutions tracked
Sentiment: unknown
No recent insider trades detected.
Red flags: 0
59 filers reported a long position in ODTX for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| FMR LLC | $96.9M | 5.2M | New |
| SR ONE CAPITAL MANAGEMENT, LP | $71M | 3.8M | New |
| TPG GP A, LLC | $69M | 3.7M | New |
| Lightspeed Management Company, L.L.C. | $67.5M | 3.6M | New |
| ORBIMED ADVISORS LLC | $56.2M | 3M | New |
| Sanofi | $37.3M | 2M | New |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $19.6M | 1M | New |
| Sands Capital Alternatives, LLC | $16.4M | 875K | New |
| HHLR ADVISORS, LTD. | $15.6M | 831.7K | New |
| General Catalyst Group Management, LLC | $15.2M | 810.3K | New |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.